Standard outcome measures for thymic malignancies

James Huang, Frank C. Detterbeck, Zuoheng Wang, Patrick Loehrer

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Thymic malignancies present particular issues due to the pace of disease progression, patterns of recurrence, and causes of death that make nuances of how outcomes are reported particularly important. The relatively limited number of patients also creates a challenge to glean as much as possible from the available experience, but risks over-interpretation and potentially misleading conclusions. Therefore the International Thymic Malignancy Interest Group has developed a set of standards for reporting of outcome measures of clinical studies, which have been adopted for collaborative projects undertaken by the organization. Widespread adoption of this baseline will enhance the ability to compare results from different series.

Original languageEnglish
JournalJournal of Thoracic Oncology
Volume6
Issue number7 SUPPL. 3
DOIs
StatePublished - Jul 2011

Fingerprint

Outcome Assessment (Health Care)
Public Opinion
Disease Progression
Cause of Death
Neoplasms
Organizations
Recurrence
Clinical Studies

Keywords

  • Mediastinal disease
  • Outcomes
  • Recurrence
  • Statistics
  • Thymic carcinoma
  • Thymoma

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine

Cite this

Standard outcome measures for thymic malignancies. / Huang, James; Detterbeck, Frank C.; Wang, Zuoheng; Loehrer, Patrick.

In: Journal of Thoracic Oncology, Vol. 6, No. 7 SUPPL. 3, 07.2011.

Research output: Contribution to journalArticle

Huang, James ; Detterbeck, Frank C. ; Wang, Zuoheng ; Loehrer, Patrick. / Standard outcome measures for thymic malignancies. In: Journal of Thoracic Oncology. 2011 ; Vol. 6, No. 7 SUPPL. 3.
@article{b788fb9523d546659d76569c36b174f6,
title = "Standard outcome measures for thymic malignancies",
abstract = "Thymic malignancies present particular issues due to the pace of disease progression, patterns of recurrence, and causes of death that make nuances of how outcomes are reported particularly important. The relatively limited number of patients also creates a challenge to glean as much as possible from the available experience, but risks over-interpretation and potentially misleading conclusions. Therefore the International Thymic Malignancy Interest Group has developed a set of standards for reporting of outcome measures of clinical studies, which have been adopted for collaborative projects undertaken by the organization. Widespread adoption of this baseline will enhance the ability to compare results from different series.",
keywords = "Mediastinal disease, Outcomes, Recurrence, Statistics, Thymic carcinoma, Thymoma",
author = "James Huang and Detterbeck, {Frank C.} and Zuoheng Wang and Patrick Loehrer",
year = "2011",
month = "7",
doi = "10.1097/JTO.0b013e3182254ac1",
language = "English",
volume = "6",
journal = "Journal of Thoracic Oncology",
issn = "1556-0864",
publisher = "International Association for the Study of Lung Cancer",
number = "7 SUPPL. 3",

}

TY - JOUR

T1 - Standard outcome measures for thymic malignancies

AU - Huang, James

AU - Detterbeck, Frank C.

AU - Wang, Zuoheng

AU - Loehrer, Patrick

PY - 2011/7

Y1 - 2011/7

N2 - Thymic malignancies present particular issues due to the pace of disease progression, patterns of recurrence, and causes of death that make nuances of how outcomes are reported particularly important. The relatively limited number of patients also creates a challenge to glean as much as possible from the available experience, but risks over-interpretation and potentially misleading conclusions. Therefore the International Thymic Malignancy Interest Group has developed a set of standards for reporting of outcome measures of clinical studies, which have been adopted for collaborative projects undertaken by the organization. Widespread adoption of this baseline will enhance the ability to compare results from different series.

AB - Thymic malignancies present particular issues due to the pace of disease progression, patterns of recurrence, and causes of death that make nuances of how outcomes are reported particularly important. The relatively limited number of patients also creates a challenge to glean as much as possible from the available experience, but risks over-interpretation and potentially misleading conclusions. Therefore the International Thymic Malignancy Interest Group has developed a set of standards for reporting of outcome measures of clinical studies, which have been adopted for collaborative projects undertaken by the organization. Widespread adoption of this baseline will enhance the ability to compare results from different series.

KW - Mediastinal disease

KW - Outcomes

KW - Recurrence

KW - Statistics

KW - Thymic carcinoma

KW - Thymoma

UR - http://www.scopus.com/inward/record.url?scp=79959840901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959840901&partnerID=8YFLogxK

U2 - 10.1097/JTO.0b013e3182254ac1

DO - 10.1097/JTO.0b013e3182254ac1

M3 - Article

VL - 6

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

SN - 1556-0864

IS - 7 SUPPL. 3

ER -